Tom Heckman
Analyst · Newbridge Securities. Please go ahead
Sure Stan, thank you, and everyone I appreciate you joining us this morning. Just as a reminder, we did file our 10Q with the SEC this morning. It's available on Edgar. It is a complete picture of the quarter and year to date through June 30. What I'll elaborate on here is some of the high points and items that I think are important for you guys to hear about. I guess overall the first quarter the second quarter was very good revenue earlier, 63% over last year's second quarter and 33% over our first quarter 2015. So pretty much any way you look at it slice and dices it was good quarter revenue wise. In fact it was our best quarter I think since back in 2011 revenue wise. So it's very good trend. We like seeing it that way. The spring, as Stan mentioned earlier than our domestic law enforcement and commercial channels, the international channel was quite frankly disappointing for the quarter in the year-to-date. A couple of things to think about there is that the U.S. dollar has been so strong, One of our biggest customers are there in Mexico and you just look at the exchange rate in Mexico alone, a year ago it was thirteen to one pieces to dollar, now it's approaching sixteen and a half to one that's almost a 30% increase in the exchange rate peso to the dollar. In other proximal projects, I think everyone remembers or hopefully you do that a year ago, we received a blanket purchase order for refurbishment parts from the PFP in Mexico that was to dominate US dollars obviously. So where we are looking at right now either 30% increase in price in dollars that they have to come up with a buy a product or they're going to buy less. So that that's kind of what's dragging us on the international side and we've got some other issues we're dealing with as well. We definitely need to improve and strengthen our international distributor network and we're in the process of doing that. We've got several initiatives going on and hopefully we'll be able to report some good progress in the third quarter in terms of the international revenues. But if we do have headwinds there that we're going to have to deal with, the U.S. domestic market has been very strong we're gaining traction primarily with packages of product as well body-worn cameras. By packages I mean where we sell as a unit body-worn camera and in-car video system and if you like our existing customers and even new customers love the fact that we can link the body-worn with our in-car video turn it on automatically, hands-free turn on and trigger mechanism the VuLink provides as well as at that point you only have one back office system to deal with for both body warm and in-car video system. So it's been very appealing to our current customers as well as new customers and we're getting our share of new customers because of the packages. The body-warns have really taken off. I know we've been reporting the number of rates out there for some time and we're finally seeing those TV's come to fruition. We do see some hesitation out there in the body warm market, because of the clarification or actually the confusion right now as to where we are brand-wise, federal government as well as state governments and they're all dealing with the brand process right now and that is causing some hesitation but we believe we're starting to see the logjam break through and you're seeing that in our second quarter revenue figures. The commercial market has really come to life, year-over-year we're more than a double in revenue and Stan and I have a standing wager we believe somewhere down the line, hopefully not the too distant future that our commercial market channel will exceed the sales of our law enforcement channels. And that's quite possible with the fleet view cloud service as we have now the tracking and monitoring system and tool that we have if it's really robust, our commercial customers love it. We see new and new deployments rather every day. In fact we're going to be feeding that market channel with some more bodies in the sales and marketing efforts in the near future. So we're going to invest some money in the commercial product side, not only products side but the sales channel side because we believe we have a product that people need in that channel now. International business obviously we talked about a little earlier. We've got to get that wrapped up. We think we've got some good ideas to get it done primarily through things that we can control, not like the foreign currency exchange rates by strengthening the international distribution system that we have, adding new distributors, providing more support for those distributors, I think you'll see some good reactions for that. But from a gross margin standpoint, we are down to a more into normal 55% in the second quarter. If you remember 39% was a gross margin in the first quarter because we had some production difficulties. We obviously addressed those in the second quarter and we believe that's step one in a two step process to get us closer to our goal of 60% gross margins overall. One thing that came out of our problems if you will in the first quarter was that we decided to go ahead and develop some standard engineering and manufacturing processes in order to become ISO and FDA certified. That would be like ISO9001 and several other certifications that we have gone through. We believe that this will help us preclude any recurrence of the problems we had in the first quarter if and when we get this thing adopted and certified and we're well on our way for that process right now. You might ask why would we get FDA certified. We, Stan and I and the Board believe that there is applications in the qualified medical field for our video products. So we're going to ahead in getting that certification now as we go to work, we're able to manufacture in the FDA environment when and if that comes. SG&A expenses increased year-over-year and from Q1 to Q2. Some of the reasons are infrequent if not nonrecurring and some are recurring in nature. Let me go through kind of recurring types of costs that we have increased in the SG&A level. First of all, we increased our headcount in the technical services department and by technical service these are the pre and post sales technicians that go out and develop planning for the infrastructure, the IT infrastructure for our customers. Not only they plan it, so even budget and prepare a good quote, but after the sale they go out and install and make sure it's working well. Obviously that's a very important part of our business that leads to happy customers down the road. And we do need to invest in that and we did invest in that and we more than doubled our size in that part during the quarter. So we are putting our money there and we believe we'll see dividends for that. Another recurring expense and we added about five people in our inside and outside sales and marketing group that's to help cover the additional TNEs that are out there as the follow-up on and hopefully conclude with the sales. So those are obviously necessary people and are happy. One other part of that those, is the number of bids that we're processing now and responding to, year-over-year we're almost three times the amount of bids that we're developing and actually issuing bids on. So we have increased the size of our group that handles the bidding process. Some of our nonrecurring expenses in SG&A, obviously the consultants we have hired some consultants to help us get the ISO and the FDA certification going that I just talked about, one other areas that I am sure everybody is concerned with is the professional fees more than doubled from last year to this year and that's primarily because of the some litigation we were involved with and hopefully you guys have seen the press release out there when we we’ve got on our litigation utility. So hopefully those are non-recurring fees, they are moving forward with one other lawsuit at this point that we hopeful have a good conclusion of the next month or two. In addition to that we have stock based compensation almost doubled this year over last year as primarily due to the increase on stock market price. Obviously that's unpredictable but it is a non-cash charge. Operating income improved by, actually operating loss improved by a 150,000 quarter-over-quarter. So that's the right direction but we're not where we want to be yet. On EBITDA basis we had a loss of 318,000 for the quarter, but if you pull out the non-recurring SG&A increases in form of the consulting for the ISO and FDA certifications in the litigation cost we would have had a positive EBITDA for the quarter. So I would say that our breakeven position for EBITDA purposes is around the $5.5 million area at the current time so you can plan on that. From a balance sheet perspective, hopefully everyone have seen the $12 million directives should offering that we completed a couple weeks ago that was priced $13.64 per share broadly and gross proceeds of $12 million day one, we use that to fully pay off, the $2.5 million of sub-debt that's been hanging out there for a couple years that is completely paid off with the proceeds of that and the rest are sitting on a balance sheet as we sit today. In conjunction with that offering, we have also issued 1.5 million warrants to purchase common shares at $13.64 a share. Now what I mean by straight warrants is there's no ratchet or abnormal anti-dilution provisions in them, therefore there is no derivative primary requirement for them, so you won't see the issues that we encountered last year and early this year with the earlier financing that we did with the convertible debt. We will not have the rate of the accounting treatment for the warrants that were issued with the $12 million offering. If you count all the warrants, if there are issued and exercise for cash plus the 12 million we’ve got upfront, this deal could result in a roughly $31 million of gross proceeds to the company, so it's a very significant deal for us. Obviously it has some huge ramifications on our balance sheet improves our financial position considerably. One other thing that I like to point out and I think we talked briefly about it was we did have a huge legal win against utility. If you recall they have filed a patent infringement suit against us. They've also started a letter writing campaign, threat letter writing campaign to our customers that we sue them for in Kansas District Court. We wrote to the Patent Board and asked them to take another look at the utility patent if they were talking as the patent that we were infringing. And we’ve got a great result where the Patent Board resend it fully 23 to 25 claims in there patent, the so called [indiscernible] patent, and the two remaining claims it stayed, we have our products do not infringe in any way. They are minor-minor depending claims. So, obviously a very big legal win for us. And really what that does, it clears the way for two things. First of all we believe that the patent infringement case that utility filed against us in Georgia Federal Court will be dismissed, if not upon request, by utility or by summary judgment if request by us. So we think that hopefully that case goes away quickly. The second piece of that is we're going to aggressively pursue damages caused by utility for this letter writing campaign in the false advertising, Libel and Slander that was out there in our Kansas case and we're excited to see where that goes. One other case is winding up here shortly, it is a Dragon Eye lawsuit. The Court is scheduled to occur in September of this year. So next month we should hopefully a good result on that litigation as well. And with that, that will stop some of the professional fees that we've been incurring this quarter year-to-date and actually even last year to some extent. So Stan?